BIotech/Medical Catalyst CalenderThis thread is designed to allow Irregulars to discuss, share and provide input for calender catalyst events, primarily but not limited to equities contained on the Green Tab of the KSS Da Man! spreadsheet that is maintained by Hi Pockets. The calender currently can be updated only by Benny, Lawrence, Dr. KSS and myself. The […]
Articles
- Most Relevant
- Most Recent
Have a question in mind that you think is so dumb you’re embarrassed to ask it? That’s what we’re here for today! This bonus post was inspired by a reader who wanted to know “where to ask a dumb question” here on Stock Gumshoe… and while his question was not actually stupid, and I’m happy […]
This is one of several ads we’ve seen over the past few months that basically say, “AI is awesome, but NVIDIA is going to collapse and some other secret stocks will be the next big winners.” Here’s how the pitch of this presentation begins: “FORMER MICROSOFT EXEC: ‘Nvidia Could CRASH on February 28’ “The AI […]
Hello Everyone I saw the text from Lazutinku , Hopefully everyone will see this thread and we get goin
Lots of questions rolling in about this one — it’s a pitch for Sean Brodrick’s Oxford Resource Explorer, which these days is offered at $79 a year (or $49 for email-only)… though the letter is actually signed by David Fessler, one of their analysts who has generally been touted as an energy and resource expert […]
This piece originally appeared as part of the Friday File for the Irregulars on July 28, but has now been unlocked for everyone. The company reported quarterly results about two weeks ago that were generally well received, and has otherwise gotten more positive press and analyst upgrades over the past month, and the shares are […]
“An opportunity this good only comes along once twice in a lifetime. “These 3 quick-action interviews with our Foolish investing experts (below) show how to prepare yourself for the $19 trillion revolution that’s swallowing up the Internet. And how to zero in on the 3 next-generation technology stocks that are best positioned to profit. “I’m […]
I always like paying attention to Chris Mayer’s recommendations — not because they’re infallible, but because he has a solid and logical process for choosing stocks, and I’ve found his arguments pretty compelling the few times I’ve heard him speak (and, of course, some of those stocks he has profiled have done well — though […]
Braden Copeland used to work for Porter Stansberry, co-editing his Stansberry’s Investment Advisory and working on Inside Strategist (since shuttered) that picked stocks based on insider buying. Earlier this year, he moved down the street to a different Agora-affiliated office to work for Bill Bonner’s son, Will, at Bonner & Partners and launch a newsletter […]
An earlier version of this article was published on January 30, 2019 — at the time, this was teased as an “inconspicuous $20 stock” that would create one-stock millionaires beginning on February 15. Now, a very similar ad with slight updates is circulating promising “one stock millionaire” status from an “unheard-of tech stock” that can […]
We see pitches about the “end of money” all the time — across the spectrum from the goofy spiel for “loyalty points” being the next Bitcoin, to actually trading in Bitcoin, to the more popular “end of America” pitch about the dollar dying and the need to have old silver coins and gold in your […]
It’s time for the parade of “what’s in the next iPhone” pitches to begin, I suppose… And actually, we’re a little late — the prognosticating about the next Apple supplier to make you rich usually starts before this point, just a few weeks before the next product announcement, so perhaps that investing theme has lost […]
This article was originally published on January 12, 2017. I have updated my disclosures and the Irregulars Quick Take, and added some comments and number updates to update my thoughts on the stock, but many of the quotes are from the earlier version of the ad and not everything has been updated. The company being […]
This update was posted on November 24, we’re re-sharing it here because of a huge number of new reader questions. It has NOT been updated or revised since we last posted an update on 11/24/2020, when Ray Blanco reporposed the ad to use the new invented target date of January 20 to replace September 22. […]
We see “Amazon can’t beat this one” ads every now and again for retailers — that was part of Oxford Club’s push for Planet Fitness earlier this week, for example — but this one is generating quite a few questions… and I haven’t written about one of Hilary Kramer’s ads for a while, so it […]
Grant Wasylik took over the newsletters that were started by Frank Curzio over at Uncommon Wisdom (one of the Weiss Research publication groups), and he’s out with a new ad for the Adventure Capitalist “back end” newsletter. That letter is one of the many “upgrade” newsletters that most publishers funnel you toward — if you […]
This article was originally published on November 13, 2013. The ad is circulating again and generating questions from readers, so we’re re-running it for you — the ad is still largely unchanged, and the three “secret” companies are still the same. The largest, FANUY, has matched the S&P with a 9% gain since the article […]
Lou Basenese has a new service over at Agora called The Takeover Alert ($1,750), and he’s all but promising that he can identify takeover targets in advance… and give you the chance to make $29,000 profits from stocks that surge dramatically in just a day. To which the first response from any reader should be, […]
We spent a fair amount of time talking about Chris Mayer’s favorite royalty stock yesterday — the main stock pitched in the newly reborn “Chaffee Royalty” teaser ad that’s been circulating lately. You can see that one and my thoughts on it here, the tease was for tiny little Sandstorm Metals & Energy. But Mayer’s […]
Today, thanks to popular demand, we’re digging into a new teaser pitch from Christian DeHaemer’s Bull & Bust Report ($99/yr) — most of the pitch is really about how the government is going to “ban” Bitcoin starting on June 16, but the bigger picture spiel is about what that means for blockchain… and for the […]
Grant Wasylik took over the newsletters that were started by Frank Curzio over at Uncommon Wisdom (one of the Weiss Research publication groups), and he’s out with a new ad for the Adventure Capitalist “back end” newsletter. That letter is one of the many “upgrade” newsletters that most publishers funnel you toward — if you […]
Yesterday we looked at one of the stocks Navellier has been pitching for his Ultimate Growth service, and today I’m moving on, as promised, to look at the second pick. And perhaps I should have swapped the order, since the ad actually called this one his “#1 Stock to Buy Today”… but, well, it seemed […]
Does anyone have any ideas what Israeli (dual headquarters in Israel and California) tech company Grant Wasylik is teasing in his latest Adventure Capitalist conference (Mar. 30, 2017)? Makes components every IoT device needs…
Today I’ve gotten bogged down in a couple articles that haven’t yet reached fruition, but I also have some good news — the redoubtable Lynn, who keeps so many things running smoothly here at Stock Gumshoe despite my best efforts to gum up the works, has gotten our initial 2017 Spreadsheet up for your consideration. […]
Pitched by Agora – Robert Burke and Louis Basenese – is this real or a stand up comedy routine. Smart Dust. An invisible network of data collection sensors …typically deployed in large swarms. They say CNN reports no one’s privacy will be secure anymore. A trillion of them by 2020. Smart Dust will transform our […]
This article was first published January 23, 2017, it has not been updated or revised. This ad caught my eye over the weekend, and it had enough clues that the Thinkolator started chugging along almost before I turned the switch this morning — so let’s dig in, and maybe we can even make it a […]
My eyes lit up when I saw the latest ad from Paul Mampilly for his Profits Unlimited newsletter — more geothermal! Woohoo! Even the ad looked familiar — we saw quite a few of those ‘heat map’ images of the US five or ten years ago when geothermal stocks “heated up,” so it gave me […]
Paul Mampilly is out with a new promo for his Extreme Fortunes newsletter, making this absurd promise: “Anyone who joins my research service Extreme Fortunes, and invests $10,000 following my recommendations, will have the chance to earn a profit of $100,000… in the next year.” So before we begin, let’s throw away that possibility. You’re […]
“Upgrade” newsletter from Ian King, focuses on targeting 1,000% gains “on every single trade” in small cap stocks ($100 million to $3 billion) that are “disruptive.” Edited by Paul Mampilly until he left Banyan Hill in 2022.
This is from Irregular Lee Salisbury: I subscribe to Mampilly’s Profit Unlimited which recommends the likes of IBM, MSFT, QRVO, STM, TER, ADSK, PYPL, etc., etc. Because I’ve found Mampilly’s service reputable I listened to his newest pitch costing a mere $2995/yr, no trials, all sales final. I didn’t buy it but have to say […]
This teaser solution first appeared as part of a Friday File that was sent to the Irregulars on January 15, 2016, so it just passed its first birthday… but so many readers are asking about it again now that we’re re-posting it for everyone to read. What follows has not been updated or revised since […]
Lots of questions rolling in about this one — it’s a pitch for Sean Brodrick’s Oxford Resource Explorer, which these days is offered at $79 a year (or $49 for email-only)… though the letter is actually signed by David Fessler, one of their analysts who has generally been touted as an energy and resource expert […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] Ho ho ho! And Happy Christmas to all […]
I always like paying attention to Chris Mayer’s recommendations — not because they’re infallible, but because he has a solid and logical process for choosing stocks, and I’ve found his arguments pretty compelling the few times I’ve heard him speak (and, of course, some of those stocks he has profiled have done well — though […]
“Save the internet” is a red flag for me. Without the Internet, of course, Stock Gumshoe doesn’t have much of a business… which would make me very sad. And, of course, crush my jet-setting lifestyle and force me to sell my private yacht. OK, fine, so my investing acumen has not yet led me to […]
“The potential gains on this invention are so big… I estimate they could easily add a whopping $914,565 to the average American’s retirement account! “So follow along with me. This could well be the biggest, easiest money ever made. “The simple invention inside that early inkjet printer – the same one that’s revolutionizing knee surgery […]
Today, for your holiday reading pleasure, we’re re-sharing a teaser solution that’s still being asked about (and apparently still being heavily promoted by the Sovereign Society folks). The original solution to this teaser appeared in a Friday File commentary, so some of you may not have seen it. I’ve excerpted most of the teaser solution […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “I live in the light of the bright summer […]
Everyone’s talking about this emerging tech revolution. It’s a $19 trillion opportunity according to Cisco. That’s trillion with a “t”—roughly the same size as the entire National Debt of the United States. One expert calls it “the largest growth opportunity in the history of humans.” So it’s no surprise that General Electric and Microsoft just […]
[Ed. Note: Dr. KSS writes about medicine biotech stocks for the Gumshoe Irregulars. He chooses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page for his past articles and most recent comments.] Assessing biotechnology stocks involves use of lots of mental microscopes and magnifying lenses. But the task […]
Recent Comments
Certainly a risk, and it's interesting that FFH was one are that specifically cut -- despite calling it out as the most obviously appealing area for investment over the past…...
I have both Defiance and YieldMax funds, I can't wait to dump them due to the NAV erosion [I have added a GTC order on all my funds to the…...
He has had long "unbeaten" records in his core strategy, which sounds like it is essentially just selling covered calls. That probably leads to stable returns, though I don't know…...
So I looked at the ingredients of the Celsius drinks and discovered the marketing BS, "natural flavors." It does not take the interested person long to discover (and most everyone…...
For sure. When I heard that he was starting a new venture concentrating on an under-represented sector of the market, I thought finally someone was going to get serious about…...
And is his guide to how to handle the old PBRG investments useful?...
Thanks for the Info.!!...
There is a new blood test, Galleri I think that’s it, that can detect most cancers via a methylation pathway. All cancers do this. Also Function Heath for $499 a…...
I like Teeka no matter the debacle at Legacy Research. I do look forward to his explanation but it won't change the fact that Teeka is really good at what…...
Sorry folks; I seem to be confusing TSM, STM and SMT. And, while at it miss-spelled "dubious". The "under the radar stock" that Weiss recommended is STM, not SMT, which…...
Correction! Pardon my dyslexia; Yesterday I wrote that Weiss was recommending STM as an "under the radar" stock, chiding them for characterizing "the world's biggest chip maker" as such. I…...
Great teaching and value. Opened up world of options that has become a major part of my investment strategy....
Pfizer - you can check the investment amount/stake of each of those Billionares. The only issue I saw is that Pfizer only had 7 FDA approvals last year, but that…...
Here is Stansberry Research's track record on ASLE: While ASLE went from 22 to 6 and I am down -$64K, FTAI went from 6 to 72, was never recommended by…...
Did you receive the Infinity "update" over the weekend? More cut and paste and pseudo quant talk. Nothing about miners or the original Infinity hypothesis. So far no updates on…...
I started a thread here on those two TSLY and NVDY. They have paid well but NVDY has more importantly held up and appreciated while TSLY has not. Active management…...
Not really. A month is just a month, and seasonality is not so critical for the southern half of the country, which is where DFH operates. Could become a concern,…...
When I saw that a while back that Ms. Woods was heavy in RXRX and the NVDA investment I picked up a few hundred shares under $6.500 around Thanksgiving 2023…...
I certainly get your point of view and feel the same. I still like to keep my options open so I plan to watch the presentation. If he has Burke…...
RXRX they bought shares of as part of a collaboration a year ago, the other holdings are much older -- Nano-X is a remnant of a venture investment that NVDA…...
Did we ever find out the names of the cryptos from Altucher...
Yep, I remember those stories -- that got a little traction after Fukushima again, as I recall (as an investment narrative, not as an actual business), but faded fast....
Hi Travis. Thank you for your relentless dedication to keep us informed and educated. I have a lifetime subscription to Weiss Ratings' "Disruptors & Dominators" . Below are the recommendations…...
At that point from a technology perspective the most valuable company will be Intel which has made the investment with ASML to take the lead. Intel's 20A and 18A processes…...
I've noted several comments in this forum which outline rather well the would be investment counselor reality and wanted to share my point of view for what its worth. I…...
Regarding your statement, "other senses dial up in intensity": I doubt that it's a matter of your other senses becoming "more sensitive." Instead, what you have probably done is simply…...
Yes, Tilson's #1 investment, the "would feel safe putting half my kids inheritance in" is still Berkshire Hathaway (he used to say, "kids college fund," but his kids are I…...
No one has weighed in on this post since 8/23. The war in Ukraine is still going on, and there is no end in sight. Whitney Tilson is back on…...
I used to value Fry's investment recommendations, but have not had a good run with his current portfolio. Out of 47 tickers in his portfolio, 21 are down and it…...
these are all good companies and viable investments that pay dividends to shareholders. that is the bedrock of sensible investing. please explain how that constitutes a scam...
these investments pay you year in and year out like clockwork. but if you're not smart enough to see that, lottery tickets probably are your best bet...
"I decided they’d had enough time to prove that they could build and compound per-share value, and had largely failed to do so" Doc - This business has "compounded" from…...
Dear Travis, I used to be in the "Gumshoe" business myself with very limited success. I'm glad I found for no other reason(s) than the time savings, the mountains of…...
I have owned Wheaton since early 2009 and have seen my shares rise from $4.11 (Canadian funds) to over $70. WPM is the best long-term streaming investment available today. They…...
I was in BWXT at $73 just prior to you October piece. See my comment there for my view then. Short answer is that this is the ONLY company with…...
Travis, you've reminded me of an old friend of mine and consummate investor who tried to buy Google on the day of its IPO. He wasn't successful then, but picked…...
What is a MILF in terms of a stock investment?...
These are strictly income focused etfs with a strong likelihood of NAV erosion. One must be very selective with these etfs; They are not for investors seeking total returns. However,…...
Ycharts tries to simulate the impact of dividend reinvestment, but I'm sure it's not perfect -- there may be a little compounding impact that doesn't show. Not much compounding to…...
I'm retired now and use REITs and MLPs to generate income. Every day Mr Market makes you an offer. I don't care about his schizo yo-yo behavior. When I look…...
Well apparently investorsplace is offering us any of their paid subscriptions as an exchange so to speak but none of our PB investments are really being talked about . Which…...
The paper that she looked at was retracted. Here is what the editors of the journal wrote: "Following publication, concerns were raised regarding a number of claims made in this…...
Actually, India's fatality rate is just below that of the US. No, India did not distribute ivermectin. You are probably referring to one state that supposedly did so....
Stansberry Research was teasing a $7 gold trade 3 years ago that they predicted would make all kinds of money, then went to a $6 gold trade in their promotions,…...
Could be, there will definitely be some big losers in that portfolio, particularly among the stocks that I bought in 2021 (though the most recent one is also doing poorly,…...
It appears that Mr. King has made this same pitch, with slightly changed wording, for the past two or three years. Checking back, expert crypto sleuths have come up empty…...
This is the strategy. Buy puts out of the money. Lose most of your investment. Enjoy " the sky is falling" newsletters and bizarre conspiracies...
I listened to it and it seemed a bit out there. I don't see panic and i can't figure out the investment premise here....
I just watched the Altshuler pitch. It is the company that Ray Blanco, Jim Rickards and Altshuler believe will go to 100x investment. This company is dependent on th x…...
WoW fantastic post Travis. Kudos Greatly appreciate esp the a January 2023-to-date chart for each. And NVIDIA is powering ahead almost the Apple for the new age of Intelligence .…...